Synpo2l-AS1: A Potent Drug Target and Potential Biomarker (G105378360)

Target Name: SYNPO2L-AS1

NCBI ID: G105378360

SYNPO2L-AS1

Other Name(s): SYNPO2L antisense RNA 1

Synpo2l-AS1: A Potent Drug Target and Potential Biomarker

Abstract:

Synpo2l-AS1, a novel antisense RNA 1, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and function have drawn significant interest, making it an attractive candidate for further research.

Introduction:

The study of RNA-based molecules, such as messenger RNA (mRNA), exonic RNA (hnRNA), and transfer RNA (tRNA), has revolutionized our understanding of gene regulation and cellular biology. These molecules play a crucial role in gene expression, translation, and post-transcriptional modification. One of the essential components of RNA molecules is the antisense RNA 1 (AS1), which recognizes and binds to specific mRNAs to prevent their translation into proteins.

Synpo2l-AS1, a novel AS1 RNA, has been identified and characterized for its unique structure and function. This RNA is highly conserved in sequence and contains a unique base pairing pattern that distinguishes it from other AS1s. Synpo2l-AS1 has been shown to interact Strongly with specific protein partners, leading to its potential as a drug target or biomarker.

Structure and Function:

Synpo2l-AS1 has a characteristic stem-loop structure, which is typical of AS1s. The loop region of Synpo2l-AS1 contains a unique base pairing pattern: GAGCGU, which is not found in any other AS1. This base pairing pattern is conserved throughout the length of the RNA and is responsible for the unique stability and stability of Synpo2l-AS1.

Synpo2l-AS1 has been shown to interact with several protein partners, including Ku70, a key regulator of microtubules, and Hu5A8, a component of the endoplasmic reticulum (ER) transport system. These interactions suggest that Synpo2l-AS1 may play a role in regulating cellular processes, including cell division, protein folding, and ER-mediated transport.

Drug Target Potential:

The unique structure and function of Synpo2l-AS1 make it an attractive candidate for drug targeting. The base pairing pattern and interactions with protein partners suggest that Synpo2l-AS1 may target proteins with similar features. Further studies are necessary to determine the specific protein targets associated with Synpo2l-AS1 and to understand its underlying mechanisms.

Biomarker Potential:

In addition to its potential as a drug target, Synpo2l-AS1 also has potential as a biomarker for various diseases. For example, Synpo2l-AS1 has been shown to be downregulated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease . This downregulation may contribute to the misfolding and misprocessing of protein biomarkers, leading to impaired sensitivity and specificity in diagnostic tools.

In addition to its potential as a drug and biomarker, Synpo2l-AS1 also has potential as a therapeutic agent. The unique structure and function of this RNA make it a novel candidate for small molecule inhibitors. Further studies are necessary to determine the efficacy and safety of Synpo2l-AS1 as a therapeutic agent.

Conclusion:

Synpo2l-AS1 is a unique and promising AS1 RNA that has potential as a drug target and biomarker for various diseases. Its characteristic base pairing pattern and interactions with protein partners suggest that it may target proteins involved in cellular processes, including cell division, protein folding , and ER-mediated transport. Further studies are necessary to determine the specific protein targets associated with Synpo2l-AS1 and to understand its underlying mechanisms. The unique structure and function of this RNA also make it a novel candidate for small molecule inhibitors, with potential as a therapeutic agent.

Protein Name: SYNPO2L Antisense RNA 1

The "SYNPO2L-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYNPO2L-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets